Cystic Fibrosis and Medical Marijuana: What Research Shows

70 minute read
0
(0)

Medical cannabis does not treat cystic fibrosis itself, and the research on it in CF is thin: mostly patient surveys, no trial of cannabis for CF symptoms. What the evidence does show is where the risk sits. Smoke and vapor land on lungs that CF already damages, and any form with CBD or THC, including oil and gummies, passes through the liver that also clears your CFTR modulator.

Based on 29 peer-reviewed studies published between 1987 and 2025

The short answer, in three layers

Smoke and vapor

Reviews written for CF care teams advise against inhaling anything, smoke or vapor, because it feeds airway inflammation and lung decline [1].

Any form, including CBD

CBD slows the liver enzyme CYP3A4, the same one that clears Trikafta and other modulators, so drug levels can shift [1][2][3].

Shared pipes and vapes

People with CF pass lung bacteria to each other. A shared mouthpiece is the same route as a shared room, only closer [4].

When does cystic fibrosis need urgent care?

Four situations need a phone call today, not a search. Call 911, or your CF center’s after-hours line if the symptoms are milder, when you notice any of these [4].

Coughing up blood

Streaks can happen during an infection and still need a call to your CF team the same day. More than a few spoonfuls, or blood that keeps coming, is an emergency.

Sudden chest pain or breathlessness

A sharp pain on one side with sudden shortness of breath can mean a collapsed lung. Read more about pneumothorax.

A blocked gut (DIOS)

DIOS, distal intestinal obstruction syndrome, is thick stool jamming the end of the small bowel. Cramping belly pain, a swollen belly, vomiting and no stool together need care the same day.

Weakness and confusion in the heat

CF sweat carries extra salt. After heat or hard exercise, weakness, cramps, headache or confusion can mean low blood sodium (hyponatremia).

Severe belly pain that spreads to the chest or back can be pancreatitis and also needs a provider now [4]. Cannabis has no place in any of these four situations: it does not replace emergency care, and it can blur the symptoms a doctor needs to see.

What is cystic fibrosis? Definition, how common it is and ICD-10 codes

Cystic fibrosis (CF) is an inherited disease caused by changes in both copies of the CFTR gene. The faulty CFTR protein cannot move salt and water properly across cell surfaces, so mucus turns thick and sticky. That mucus clogs the airways and traps bacteria, blocks the ducts of the pancreas so food is poorly digested, and makes sweat unusually salty [5].

Nearly 40,000 children and adults in the United States, and more than 100,000 people worldwide, live with cystic fibrosis [6]. How common it is depends on ancestry: about 1 in 2,500 to 3,500 white newborns, 1 in 17,000 African American newborns and 1 in 31,000 Asian American newborns [5]. In Spanish the condition is called fibrosis quística. The Cystic Fibrosis Foundation accredits the network of CF care centers where most people in the US are followed.

Cystic fibrosis symptoms and effects on the body

CF touches almost every organ that makes mucus. The lungs decide most of the course, but the gut, the salt balance and the liver shape everyday life just as much.

Lungs and sinuses

A daily wet cough, repeat chest infections, flare-ups called pulmonary exacerbations, widened damaged airways (bronchiectasis) and nasal polyps. Inhaled antibiotics from the aminoglycoside family, used for years, can affect the kidneys and hearing.

Pancreas, gut and liver

Most people need enzyme capsules with every meal because the pancreas cannot deliver its own. Fat and vitamins are poorly absorbed. CF-related diabetes (CFRD), DIOS and CF liver disease are common later on [4].

Sweat and salt

Sweat carries several times the usual salt. In hot weather or during exercise the body loses sodium fast, and low sodium shows up as tiredness, cramps or confusion.

Bones, fertility and growth

Thin bones are common in adults. Most men with CF are infertile because the sperm ducts did not form, though they can still father children with assisted reproduction. Women with CF can and do get pregnant.

In babies, the first sign is often a bowel blocked at birth (meconium ileus), slow weight gain despite a good appetite, or skin that tastes salty when kissed. Every newborn in the US is screened, so most diagnoses now come in the first weeks of life [7].

Can cystic fibrosis develop later in life? It cannot appear later, because it is present from birth. It can be found later: people with milder gene variants are sometimes diagnosed as teenagers or adults after years of sinus trouble, pancreatitis or infertility.

Pain, anxiety and low mood are part of the condition for many people. A 2023 review pooled anxiety at 22.8% of people with CF and depression at 19% of adolescents with CF [1]. Those are also the symptoms that bring people to ask about cannabis.

Cystic fibrosis ICD-10 codes

ICD-10-CM codes used on medical records and insurance claims for cystic fibrosis [8]
CodeWhat it covers
E84.0Cystic fibrosis with pulmonary manifestations [8]
E84.11Meconium ileus in cystic fibrosis [8]
E84.19Cystic fibrosis with other intestinal manifestations, such as DIOS [8]
E84.8Cystic fibrosis with other manifestations [8]
E84.9Cystic fibrosis, unspecified [8]
Z14.1Cystic fibrosis carrier: one changed CFTR gene, no disease [8]

How cystic fibrosis is inherited · Is it contagious?

Is cannabis worth raising with my CF team?

Thirteen short questions about your lungs, your medicines and the symptom you want help with. At the end you get a plain reading of where your situation fits what is known, and what to take to your CF team and a physician. This is not a diagnosis, and nothing is stored against your name.

13 questions · about a minute · your answers stay in this browser

Question 1 of 13

How old are you, or the person you are asking for?

Is cystic fibrosis genetic? How it is inherited, carriers and genetic testing

Cystic fibrosis is genetic and inherited in an autosomal recessive pattern: a child has CF only when both copies of the CFTR gene carry a change, one copy from each parent [5]. You cannot develop it from something you did, and you cannot catch it.

A person with one changed copy and one working copy is a carrier. Carriers have no symptoms, and most have no idea until a relative is diagnosed or a carrier screening test comes back positive. Many different changes in the CFTR gene exist, and which ones a person carries decides whether a modulator can work for them at all [9].

Carrier screening uses a blood or saliva sample or a cheek swab [7]. It is often offered before or early in pregnancy, and to relatives of someone with CF. What it costs depends on your insurance and on how many variants the test looks for, so ask the lab or a genetic counselor for the price before the sample is taken.

What are the odds for a child?

How to read it: each parent passes on one of their two copies of the CFTR gene, chosen by chance, for every pregnancy. Pick what each parent has and the four squares show the four equally likely combinations.

Parent 1

Not sure? Carriers have no symptoms. A carrier screening test answers this, and your CF center or genetic counselor has the result.

Parent 2

A parent with a negative carrier test can still carry a rare variant the test did not look for. Ask the counselor what the test covered.

–

Chance of CF

–

Chance of being a carrier

–

Chance of neither

Choose both parents to see the odds.

Every combination as a table
Chances for each pregnancy, by what the two parents have
ParentsCFCarrierNeither
Carrier and carrier [5]25%50%25%
Carrier and no variant [5]0%50%50%
Has CF and carrier [5]50%50%0%
Has CF and no variant [5]0%100%0%
Has CF and has CF [5]100%0%0%
No variant and no variant [5]0%0%100%

The odds start over with every pregnancy. Two carrier parents with one child who has CF still face the same one in four chance next time, and a first child without CF does not lower it.

Is cystic fibrosis contagious? Cross-infection and isolation precautions

Cystic fibrosis is not contagious. Nobody catches CF from a person who has it, through touch, breath or a kiss, because it is a gene change present from birth. What can travel between people with CF are the germs that settle in CF lungs.

What cannot be caught

The disease itself. Friends, partners, classmates and coworkers are not at risk of getting CF by spending time with someone who has it. Family members can share the gene, which is a question for carrier testing, not for distance.

What can pass between people with CF

Bacteria that thrive in thick mucus, such as Pseudomonas aeruginosa, the Burkholderia cepacia complex and nontuberculous mycobacteria. They are harmless to most people and dangerous to another lung with CF.

That is why people with CF are asked to stay at least 6 feet apart from each other [4], why CF clinics book visits so patients do not share a waiting room, and why staff wear gowns and gloves in exam rooms. These isolation precautions protect the patient in the next room, not the general public. Clean hands before meals and treatments are the everyday half of the same habit [4].

What smoke and vapor do to CF lungs

How is cystic fibrosis diagnosed? Newborn screening, sweat test and genetic testing

Diagnosis rests on two tests read together: how much salt is in the sweat, and which CFTR gene changes a person carries. In the US the path usually starts at birth [7].

1. Newborn screening

All newborns in the US are tested within the first two or three days of life, with a heel prick blood sample. A positive screen is a flag, not a diagnosis [7].

2. Sweat chloride test

The standard test. 60 mmol/L or higher points to CF, 30 to 59 is unclear and needs more testing, under 30 makes CF unlikely [7].

3. CFTR genetic test

DNA from blood, saliva or a cheek swab shows which variants are present, which also tells the team which modulator may fit [7].

Diagnosis in adults follows the same tests, started by symptoms rather than a newborn screen: years of sinus infections, a cough that never fully clears, pancreatitis, or infertility in a man. An unclear sweat result in an adult is common with mild variants, and the genetic test usually settles it [7].

Once diagnosed, most people in the US are followed at an accredited CF care center: a pulmonologist, a dietitian, a respiratory therapist, a social worker and a pharmacist who see you several times a year. That team is also the right first audience for any question about cannabis.

Can you treat or cure cystic fibrosis? CFTR modulators, airway clearance and transplant

There is no cure for cystic fibrosis yet, but it is very treatable, and treatment has changed more in the last decade than in the forty years before. Care rests on five pillars. Open each one.

CFTR modulators: Trikafta, Alyftrek, Kalydeco, Symdeko, Orkambi

Modulators are pills that help the faulty CFTR protein work better. The triple combination elexacaftor/tezacaftor/ivacaftor (Trikafta) can be used by up to 90% of people with CF [9]. Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) is the newer once-daily triple. Ivacaftor alone (Kalydeco), tezacaftor/ivacaftor (Symdeko) and lumacaftor/ivacaftor (Orkambi) cover other variants and younger children.

They only work for certain CFTR variants, and people of Asian, Black and Hispanic ancestry are more likely to carry variants they do not help [9]. Your CF center matches the drug to your genes. All of them are cleared by the liver enzyme CYP3A4, which is the reason this page keeps coming back to them.

Airway clearance and inhaled medicines

Breathing techniques, positive expiratory pressure devices, chest physiotherapy and vibrating vests loosen mucus so it can be coughed up [9]. Inhaled dornase alfa thins it, hypertonic saline draws water into it, and inhaled antibiotics hold chronic infections down. Many people still spend an hour or more a day on this.

Enzymes and vitamins

Pancreatic enzyme replacement (PERT) capsules go with every meal and snack, and the fat-soluble vitamins A, D, E and K are checked and replaced [4].

Lung and liver transplant

When lung disease is advanced, a lung transplant is an option, and some people with severe CF liver disease receive a liver transplant [9]. Transplant centers assess substance use as part of listing, covered in the transplant section below.

Gene and mRNA therapies

Therapies that deliver a working copy of the gene or its instructions are being tested in clinical trials. None is approved yet, and they are the closest thing to a cure on the horizon.

Cannabis is not part of standard CF care and does not stand in for any of these pillars. Nothing on this page is a reason to skip a treatment, lower a dose or stop a modulator; changes go through the CF team.

Cystic fibrosis diet: calories, salt, enzymes and vitamins

The classic CF diet is high in calories and fat, because poorly absorbed food and the work of breathing burn energy fast [4]. On modulators, absorption often gets better and many adults now gain weight easily, so dietitians tailor the plan rather than push calories by default.

  • Enzymes with every meal and snack that contains fat, timed as the dietitian says.
  • Extra salt and fluid on hot days and during exercise; some people use salt tablets or salty snacks on the advice of their team [4].
  • Vitamins A, D, E and K as a CF-specific supplement, with blood levels checked.
  • With CF-related diabetes, carbohydrates are planned with insulin rather than cut; blood sugar testing usually starts at age 10 and is repeated every year [4].

Low appetite and weight loss during flare-ups are among the reasons people with CF ask about cannabis. That question belongs with the dietitian as well as the physician.

When cannabis is worth raising, and when it is not

Cystic fibrosis life expectancy: how long can you live, is it fatal, and the cancer question

Children born with cystic fibrosis between 2019 and 2023 are expected to live 61 years on average, and half of babies born with CF in 2023 are expected to reach 68 or older [6]. A generation ago, most people with CF did not reach adulthood.

Those figures are estimates for a whole group. Your own outlook depends on your gene variants and whether a modulator works for them, how well your lungs are holding up, how often infections flare, and access to a CF center. People born in 1995, 2000 or 2010 grew up before or alongside the triple modulators, so the estimates made for their birth years were drawn up with older treatment in mind; your CF center can tell you what your own numbers suggest [6].

Is cystic fibrosis fatal? It is still a life-shortening disease, and lung failure remains the most common cause of death. It is not a terminal diagnosis in the sense of a short countdown: most people with CF in the US are now adults who work, study and raise families.

The cancer question. People with CF have a higher risk of colorectal cancer, so regular colorectal screening is recommended from age 40, earlier than for the general population [4]. Ask your team when your first colonoscopy is due.

One thing every source agrees on: smoke shortens lung life. Tobacco smoke, including second-hand smoke at home, worsens CF lung disease, and that is the starting point for the cannabis question below.

With cystic fibrosis, is medical cannabis worth raising for you?

Hours of airway clearance before school or work. Enzymes counted out for every meal. Nebulizers, pill organizers, clinic days, the occasional two weeks of IV antibiotics. And under it all, the worry that comes with every new cough. Many people with CF add pain, poor sleep, low appetite and anxiety to that list, and some are tired of being offered one more prescription for each.

That is usually when cannabis comes up, often quietly, because people expect to be judged. Raising it with a physician is reasonable for some symptoms and pointless for others.

Where the question makes sense

Long-lasting pain in the chest, joints, head or belly. Low appetite and weight that will not hold. Nausea. Sleep broken by coughing or worry. Anxiety that is wearing you down. These are the symptoms a physician can weigh cannabis against, alongside what you already take.

What cannabis does not do

It does not improve lung function, clear infections, thin mucus or correct the CFTR protein. It does not replace a modulator, airway clearance, enzymes or antibiotics. No study on this page suggests otherwise.

In one US survey of 96 adults with CF, the reasons people gave for using cannabis or CBD were sleep (33%), anxiety (30%) and pain (30%) [2]. Lungs and infections were not on the list, and that matches what the research can support.

Why researchers study cannabinoids in cystic fibrosis: the endocannabinoid system, CB2 and inflammation

The interest starts with inflammation. In CF airways, missing or faulty CFTR leaves the airway surface too dry, mucus traps bacteria, and the body answers with a flood of white blood cells called neutrophils. Those cells release enzymes and reactive molecules that damage the lung they are trying to protect, and the cycle keeps itself going [10].

The body has its own system for turning inflammation and pain signals down: the endocannabinoid system, made of cannabis-like molecules the body produces and the receptors they bind to. CB1 receptors sit mostly in the brain and nerves; CB2 receptors sit mostly on immune cells, which is why researchers looking at CF inflammation focus on CB2.

THC is a partial agonist at both CB1 and CB2: it switches them on, though not fully. That produces the familiar high, pain relief and anti-inflammatory effects. CBD works differently. It activates TRPV1, a receptor that lowers how easily nerves fire, and blocks GPR55, which reduces calcium release inside cells [1].

Both are broken down in the liver by the cytochrome P450 enzymes CYP2C9, CYP2C19, CYP3A4, CYP2D6 and CYP1A2 [1]. That detail matters more for CF than the receptor biology, because CFTR modulators use the same route.

The anti-inflammatory idea has been tested with lenabasum, a synthetic compound that acts on CB2 and was studied in controlled trials in people with CF as an approach to airway inflammation [10]. Lenabasum is not cannabis and not a CBD product, and results from it do not transfer to anything sold under a medical card.

What the research on cannabis and cystic fibrosis shows, from strongest to weakest

The evidence is limited. Among the studies that look directly at people with CF and cannabis, there is no trial that gave cannabis or CBD for CF symptoms and compared it with a placebo. Almost everything comes from surveys that asked people what they use and why, from reviews that summarize other work, and from one case report. Strong designs are few, so nothing here can be generalized to everyone with CF.

Reviews

Two narrative reviews, meaning expert summaries rather than pooled data, frame the field. A 2023 review on teenagers with CF weighs lung, brain, mental health and drug-interaction risks and advises against unprescribed cannabis use in adolescents with CF, recommending that care teams screen every patient and talk it through rather than order routine urine drug tests [1]. A 2021 review on CF airway inflammation explains why cannabinoid receptors interest researchers at all [10].

Surveys and cross-sectional studies

Six studies asked people with CF directly, in Canada and the US. They show that cannabis and CBD use is common and mostly medical in intent, that people use it for sleep, anxiety and pain, and that the conversation with the CF team often never happens [3][2][11][12]. Everything in them is self-reported, response rates were low, and none measured whether symptoms actually improved. The numbers are in the next section.

Case report

One published case describes a young man with CF who smoked cannabis through a bong and developed large air-filled spaces in both upper lungs, repeated collapsed lungs and an infected flare of his bronchiectasis [13]. A single case cannot tell us how often this happens. It illustrates what the worst version of inhaled use can look like in CF lungs.

Browse the studies yourself

Every study named on this page, with its design and what it found, including the neutral and negative ones. Filter by the kind of evidence you want to see.

2025 · Survey · 110 adults, one Canadian CF clinic [3]

Cannabis and vaping after legalization in adults with CF

43% were current cannabis users and 85% of them used it for medical reasons; 64% of current users said it improved their quality of life, by their own account [3].

2025 · Cross-sectional survey · 226 people with CF [12]

Do CF teams talk about substance use?

Risks and benefits of marijuana had been discussed with 47% of participants, against 88% who had been asked about cigarettes; 35% rated their team’s marijuana knowledge good to excellent [12].

2024 · Chart review and survey · 373 records, 96 respondents [2]

How common is CBD use in adults with CF?

15% of charts recorded current cannabis use; 11.5% of respondents used CBD now and 21.9% were interested. 72% of CF clinicians felt under-prepared to answer CBD questions [2].

2024 · Cross-sectional study · 226 people with CF over age 13 [11]

Time to be blunt: substance use in CF

In the past year 29% had used marijuana and 22% CBD; 23% of marijuana users used it daily or nearly daily. After adjustment, use was not clearly linked to modulator use [11].

2023 · Survey · 205 adolescents and young adults with CF [14]

Tobacco and marijuana perceptions in young people with CF

Nearly all, 98.3%, said they were unlikely to smoke cigarettes in the next six months, yet 31.8% of those aged 18-21 had tried e-cigarettes [14].

2020 · Survey · adults with CF [15]

Use of medical marijuana in CF patients

Asked people with CF how and why they use medical marijuana and what they think of it. The authors also point out that CF modulator therapies may switch on the liver enzyme CYP1A2, which matters for interactions [15].

2023 · Narrative review [1]

Clearing up the smoke: cannabis in adolescents with CF

Advises against unprescribed use in teens with CF because of lung, cognitive, psychiatric and drug-interaction risks, and recommends routine screening conversations over urine tests [1].

2021 · Narrative review [10]

Dysfunctional inflammation in CF airways

Explains the neutrophil-driven inflammation of CF lungs and the anti-inflammatory approaches under study, including cannabinoid receptor targets. Not a test of any cannabis product [10].

2010 · Case report · 1 patient [13]

“Bong lung” in cystic fibrosis

Large bullae in both upper lobes, recurrent pneumothoraces and an infective flare of bronchiectasis in a young man with CF who smoked through a bong [13].

What kinds of studies is this evidence built on?

How to read it: each row is one kind of study, and the number at the end of the bar is how many published studies on cannabinoids and cystic fibrosis use that design. Designs near the top carry the most weight. The gray bars at the bottom are expert summaries and animal or laboratory work, useful for ideas, not proof that something helps people.

Surveys and cross-sectional studies outnumber trials by more than two to one, and the trials that exist tested a synthetic anti-inflammatory compound rather than cannabis or CBD, which is why the conclusions on this page stay cautious.

Show as a table
Study designNumber of studies
Systematic review2
Randomized trial2
Clinical trial3
Cohort study1
Cross-sectional study5
Survey6
Case report1
Narrative review5
Animal study1
Laboratory study1

How people with cystic fibrosis actually use cannabis: what surveys found

If you have wondered about cannabis, you are far from alone. In a Canadian CF clinic, more than four in ten adults were current users. Pick a study to see what it found and what limits it carries.

110 adults with CF or a CFTR-related disorder, Canada [3]

43%

were current cannabis users; 72% had ever tried it [3]

85%

of current users used it for medical reasons [3]

64%

of current users said it improved quality of life [3]

Vaping changed meaning after the 2019 wave of vaping-related lung injury: 45% said media coverage of EVALI changed how they see vaping, and 7% vaped at the time of the survey [3]. Design: self-reported questionnaire at one clinic, filled in by 37% of those eligible; adolescents were excluded and modulator use was not assessed.

373 adult medical records and 96 survey respondents, US [2]

15%

of records noted current cannabis use [2]

11.5%

of respondents used CBD now; 20.8% had in the past [2]

72%

of CF clinicians felt under-prepared for CBD questions [2]

Another 21.9% had never used CBD but were interested, and 44.8% had no plans to. Sleep, anxiety and pain were the top reasons [2]. Design: chart review plus survey; CBD is hard to record on a medication list, so the chart figure likely undercounts.

226 people with CF over age 13, US [11]

29%

used marijuana in the past 12 months [11]

22%

used CBD in the past 12 months [11]

23%

of marijuana users used it daily or nearly daily [11]

For comparison, 27% had used e-cigarettes and 22% cigarettes in the same year; 56.6% had never tried marijuana [11]. Design: a one-time, self-reported survey; it shows how common use is and cannot show cause and effect.

226 people with CF rating their care teams, US [12]

47%

had discussed marijuana’s risks and benefits with their team [12]

88%

had been asked about cigarette use [12]

35%

rated the team’s marijuana knowledge good to excellent [12]

The gap between being asked about cigarettes and talking about cannabis is the practical finding here [12]. Design: self-reported survey; it measures the conversation, not the health effects.

Questions to bring to your CF team

How big is the effect, in numbers

No study in people with CF has measured how much cannabis relieves pain, sleep, appetite or anxiety. The survey figures above are how many people use it and what they report, not the size of a benefit. The numbers that do come with a confidence interval describe risks and links, and they are below with that label attached.

What is known about cannabis and mental health in young people?

How to read it: each row compares young people who use cannabis with those who do not. The dot is the best estimate of how much more often the outcome happened; the bar is the likely range (95% confidence interval). The gray line is “no difference”. A hollow dot means the range crosses that line, so no clear difference was found. These are general-population studies of youth collected in a 2023 review, not studies of people with CF [1].

Heavy cannabis use in young people went with psychosis about four times as often and with suicide attempts about three and a half times as often; for anxiety the studies found no clear difference. These are associations, not proof that cannabis caused them [1].

Show as a table
OutcomeComparedOdds ratio (95% CI)
Anxiety developing [1]Young adult users vs non-users1.18 (0.84-1.67)
Suicide attempt [1]Young users vs non-users3.46 (1.53-7.84)
Schizophrenia or other psychotic disorder [1]Heavy users vs non-users3.9 (2.84-5.34)
Being on a CFTR modulator (people with CF) [11]Marijuana users vs non-users, adjusted2.45 (0.97-7.17)

What this means for teens with CF

What science doesn’t know yet about cannabis and cystic fibrosis

About four in ten studies in this field end without a clear answer. The open questions are specific, and each one bears on a real decision.

  • Nobody has tested cannabis or CBD against a placebo for pain, sleep, appetite or anxiety in people with CF.
  • Nobody has followed lung function (FEV1, the amount of air you can blow out in one second) over years in people with CF who use non-inhaled cannabis.
  • How CBD and THC change modulator levels in real patients has been worked out from pharmacology, not measured in people with CF on Trikafta or Alyftrek [2].
  • Fat malabsorption changes how fat-soluble drugs are absorbed, and cannabinoids are fat-soluble. How much of an oil or edible actually reaches the blood in someone with pancreatic insufficiency is unknown.
  • The surveys rely on self-report, came from single clinics or social media, and were answered by roughly a third of those invited [3].
  • Teenagers were left out of the largest adult survey, and evidence on benefits in children with CF is close to nonexistent [1].
  • People after a lung transplant are almost absent from the data, though they take the medicines most exposed to interactions.

Protect your lungs first: cannabis smoke and vapor with cystic fibrosis

Smoking or vaping cannabis with cystic fibrosis works against the lungs. Inhaling any substance can worsen airway inflammation and speed up lung damage in CF, which is why the reviews written for CF teams discourage inhaled cannabis of every kind [1][15]. That is a verdict on the route, smoke and vapor, not on cannabis as a whole.

Smoke. Burning plant material produces hot smoke full of irritants. In CF airways it slows the tiny hairs (cilia) that sweep mucus out, weakens the airway’s defenses against bacteria and adds inflammation on top of the inflammation CF already drives [1]. Smoke exposure can also blunt how well CFTR works, which may undercut part of what a modulator does [11].

Vaping and dabbing. A vaporizer or a dab rig heats rather than burns, so there is no smoke, but a hot aerosol still travels down the same airways. After the 2019 outbreak of vaping-associated lung injury (EVALI), 45% of adults surveyed at one Canadian CF clinic said the news changed how they saw vaping [3]. Read more about acute lung injury.

What the worst case looks like. A published case describes a young man with CF who smoked through a bong and developed large air-filled bullae in both upper lungs and repeated collapsed lungs [13]. That is one patient, not a measure of risk, and it is the reason a sudden chest pain in a person with CF who inhales anything needs an emergency check; see pneumothorax.

Second-hand smoke around a child with CF. A child’s CF lungs breathe whatever is in the room or the car. The same advice applies to cannabis smoke as to tobacco smoke; read about the risks of smoking cannabis around children.

Forms that are not inhaled skip the airways. They do not skip the liver, the medicine interactions or the effects of THC, which is what the next two sections are about.

Form by form · Interactions with CF medicines

Smoked, vaped, eaten, under the tongue or on the skin: what each form avoids and what stays with cystic fibrosis

Cannabis is not one thing you smoke. Medical products are also eaten, swallowed as capsules, held under the tongue, rubbed on the skin or worn as a patch, and each route changes which CF risks apply. No study compares the forms with each other in people with CF, so nothing below ranks one as safer.

Pick the form you use or are asking about. Each one is shown in three layers: the airways, what applies to any form, and what else to keep in mind.

Smoked: joints, blunts, pipes and bongs

Airways
The heaviest layer for CF. Smoke inflames airways that are already inflamed and is the route behind the “bong lung” case report [1][13].
Any form
THC still reaches the brain and is still handled by the liver, so drowsiness, slower reactions and interactions with modulators apply as well [1].
Also keep in mind
A joint or pipe passed around a group carries bacteria between mouths. A blunt wraps cannabis in tobacco leaf, adding tobacco smoke.

Vaped or dabbed: dry-herb vaporizers, oil pens, concentrates

Airways
No burning, still a hot aerosol in the same airways. CF reviews discourage inhalation from any source, vapor included [15].
Any form
Liver handling, interactions and THC effects are the same as for any other route. Concentrates used for dabbing carry far more THC per dose than flower.
Also keep in mind
Cartridges bought outside a state program were at the center of the EVALI lung-injury outbreak. A shared pen is a shared mouthpiece.

Edibles: gummies, chocolate, baked goods

Airways
Bypassed. Nothing is inhaled.
Any form
Everything swallowed goes through the liver before it reaches the blood, the same stop where CBD slows the enzyme that clears modulators [1][2]. The effect starts late and lasts for hours; taking more because nothing seems to be happening is a common way people take far too much.
Also keep in mind
Gummies and chocolate carry sugar, which counts with CF-related diabetes. With pancreatic insufficiency, how much of a fat-based edible is absorbed has not been studied.

Capsules and drinks

Airways
Bypassed.
Any form
Swallowed, so the liver and the modulator interaction apply exactly as for edibles. A capsule states its dose, which makes it easier to tell your team precisely what you take.
Also keep in mind
Drinks can be sipped over an hour, so the dose arrives slowly and is easy to misjudge.

Under the tongue: tinctures, oils and mouth sprays

Airways
Bypassed.
Any form
Some is absorbed through the lining of the mouth and the rest is swallowed, so the liver and the interactions still apply. Sleep and anxiety were among the top reasons people with CF gave for using cannabis or CBD in one survey [2].
Also keep in mind
Droppers are imprecise. Write down the product, the strength on the label and how many drops, so your team sees the real amount.

Creams, balms and ointments

Airways
Bypassed.
Any form
Made to act where they are rubbed in, with little meant to reach the bloodstream. They have not been studied in CF at all, so they are still worth listing for the team.
Also keep in mind
Check the label for added ingredients if your skin reacts to fragrances or menthol.

Transdermal patches

Airways
Bypassed.
Any form
Unlike a cream, a patch is built to push cannabinoids through the skin into the blood, steadily, for hours. That puts it with the swallowed forms for drowsiness and for interactions with modulators.
Also keep in mind
The dose keeps arriving until the patch comes off, which matters before driving.

Suppositories

Airways
Bypassed.
Any form
Absorbed into the blood, so interactions and THC effects apply. Rarely used, and with very little data of any kind.
Also keep in mind
Anyone with a history of DIOS or bowel surgery should raise this route with the CF team specifically.

Prescription cannabinoids: dronabinol, nabilone, Epidiolex

Airways
Bypassed. All are taken by mouth.
Any form
Dronabinol (Marinol, Syndros) and nabilone (Cesamet) are synthetic THC-like drugs, and Epidiolex is prescription cannabidiol. They are FDA-approved medicines from a prescriber and a pharmacy, not products bought with a medical card, and the pharmacist checks them against your CF medicines.
Also keep in mind
A review describes dronabinol at 5 mg twice a day being used for severe malnutrition in CF, with an average gain of about 7 lbs over three months [1]. That is what was used in that setting, not a dose to copy.

None of these routes is a recommendation. Which form, if any, fits your lungs, your liver tests and your medicine list is a decision for you and a physician who has all three in front of them.

Cannabis with Trikafta, Alyftrek, Kalydeco and other CF medicines

Higher modulator levels can mean more side effects; changes in the other direction can mean less benefit. These findings come from how the drugs are processed, not from studies that measured levels in people with CF who use cannabis. Open each pair for what is known.

CBD with Trikafta or Alyftrek (triple modulators)

CBD may inhibit CYP3A4 and raise exposure to elexacaftor, tezacaftor and ivacaftor, increasing the chance of their side effects. Evidence type: pharmacokinetic [3][1]. The same applies to the components of Alyftrek, which use the same pathway.

THC with any CFTR modulator

THC and modulators compete for the same CYP3A pathway, which can lead to treatment failure or to more adverse reactions. Evidence type: pharmacokinetic [2][1]. One survey also notes that modulator therapies may induce CYP1A2, another enzyme involved in cannabinoid breakdown; evidence type: mechanistic [15].

THC with antidepressants

THC inhibits CYP2D6, an enzyme that processes many antidepressants, so their levels can rise. Evidence type: pharmacokinetic [1].

Cannabis during a flare treated with steroids

Corticosteroids used for pulmonary exacerbations have been linked with psychosis when combined with cannabis. Evidence type: clinical reports summarized in a review [1]. A flare is a time to pause and ask, not to add.

Antifungals for ABPA and anti-rejection medicines

General pharmacology, not tested in the studies on this page: azole antifungals used for allergic bronchopulmonary aspergillosis (ABPA) and anti-rejection drugs such as tacrolimus after a transplant also depend on CYP3A4. Ask your pharmacist to check them against any cannabis or CBD product.

Sedating medicines and liver tests

THC adds to the drowsiness of sleep aids, opioids and other sedating drugs. Modulators already come with liver monitoring; ask whether adding anything changes how often your liver enzymes are checked. More on drug-induced liver injury.

Clinicians are advised to ask every patient about CBD because of these interactions [2]. If nobody has asked you, say it first. Do not stop, skip or change a modulator or any other CF medicine on your own; bring every bottle, over-the-counter ones too, to your CF pharmacist and let them check each pairing.

Questions to take to your CF team

Is cannabis safe with cystic fibrosis? Side effects and who should not use it

Cannabis carries real side effects, and some weigh more with CF. The studies on this page record trouble concentrating and changes in energy among marijuana and CBD users, dizziness, drowsiness and fatigue, anxiety and paranoia, dependence, stomach effects including cannabinoid hyperemesis syndrome (cycles of severe vomiting with heavy long-term use), impaired driving and worsening breathing symptoms with inhaled use [3][11][1]. In heavy smokers, lung function (FEV1) and lung density fall [1].

Teens and young adults with CF

A 2023 review written for pediatric CF teams advises against unprescribed cannabis use in adolescents with CF, citing risks to the lungs, to thinking and memory (including a fall in IQ with early heavy use), to mental health, and from drug interactions [1]. The same review reports that 15.4% of 16-year-olds with CF treated at centers in New Jersey and Pennsylvania used cannabis and 46% were interested in trying medical cannabis [1]. If you are a parent, the first conversation belongs with your child’s pediatric CF team, and the review recommends they ask every teen about it.

Who should not use cannabis, or only with the specialist who treats them

  • Anyone who is pregnant or breastfeeding: there is no evidence of safety, and CF pregnancies are already closely managed.
  • Anyone with a history of psychosis or schizophrenia, given the association with psychotic disorders in heavy users [1].
  • Teenagers using it without a physician involved [1].
  • People with CF liver disease or raised liver enzymes, because modulators and cannabinoids share the same liver pathways [2].
  • People with CF-related diabetes choosing sugary edibles, unless the carbohydrates are planned like any other food.
  • Anyone in a pulmonary exacerbation on steroids, given the reports of psychosis with that combination [1].
  • Anyone driving or operating machinery after a dose, with any form.

Lung transplant lists, drug tests, work, firearms and privacy

If you are being evaluated for a lung transplant, or are already listed, ask your transplant center about its cannabis policy before using any form. Cannabis use recorded in your chart can come up during evaluation, and researchers name concern about medical records and transplant eligibility as a real barrier for people with CF [2]. Centers set their own rules; this page cannot tell you what yours will decide.

After a transplant, anti-rejection drugs such as tacrolimus run through the same liver enzyme as CBD and THC. That is general pharmacology rather than a finding from the studies here, and it is the reason your transplant pharmacist should see any product before you start it.

Work, firearms and privacy, briefly

A medical card does not override an employer’s drug-testing policy, especially in federally regulated jobs. Cannabis remains illegal under federal law, which affects firearm purchases, since the federal purchase form asks about marijuana use. Your evaluation is a medical appointment handled as protected health information, and state patient registries are confidential. The rules for your state are on medical marijuana laws by state, and common questions are answered on the medical card FAQ.

Questions to ask your CF team about medical cannabis

In one survey of 226 people with CF, only 47% had ever discussed marijuana’s risks and benefits with their care team [12]. You do not have to wait to be asked, and the appointment goes better when you bring the details.

What to write down before the appointment

  1. Every medicine and supplement with doses, starting with your modulator and any antidepressant, antifungal or anti-rejection drug.
  2. Anything you already use: the form, the THC and CBD content from the label, how much and how often.
  3. Your latest lung function result and when your last flare-up was.
  4. Your transplant status, if a transplant has been discussed.
  5. The one symptom you most want help with, and what you have already tried for it.

Questions worth asking

Tick the ones you want to bring. Nothing is saved.

Does cystic fibrosis qualify for a medical marijuana card?

Whether cystic fibrosis qualifies depends on how your state words its list of qualifying conditions. A licensed physician has to match you to that wording, so the same diagnosis can qualify in one state under one line and in another state under a different one. Your situation usually falls into one of three cases.

Named on the list

If your state’s list names cystic fibrosis, your diagnosis itself is the qualifying line, and your CF center records are what the physician reviews.

Check your state’s list

Covered by a symptom line

More often the route runs through a symptom the list does name: severe or chronic pain, cachexia or wasting, severe nausea. Documented weight loss or long-lasting pain is what counts there.

See how states word it

Left to the physician

Some states let a physician certify a debilitating condition that is not named, or keep a petition process for adding one. That decision happens during the evaluation.

Read your state’s program rules

State facts at a glance: what to look up for your state

Four facts change what a card means for you, and each one differs by state: the legal status (medical only, or medical plus adult use), the possession limit for registered patients, the taxes a card removes or lowers, and whether patients may grow at home. Each state’s page on medical marijuana laws by state sets these out with its own figures, so they are not repeated here.

Patients under 18 and caregivers in state law

Cystic fibrosis is usually diagnosed in infancy, so many readers are parents. State programs that allow minors as patients generally require a parent or legal guardian to register as the minor’s caregiver, and some require a second physician’s agreement. Adults who are too ill to buy for themselves can, in many states, name a registered caregiver. These rules belong to each state program and vary widely; the details for yours are on the state laws pages, and the first conversation for a child is with the pediatric CF team.

After a recommendation: can you go to a dispensary right away?

In some states the signed recommendation is what a dispensary asks for. In most, it is the first of two steps: you then register with the state program, which issues the card on its own schedule. Your recommendation and the state’s instructions sit together in your account.

How to get a medical card online: steps, price and what happens next

You do not travel to a clinic for any of it, and the steps are the same whichever line of your state’s list covers your CF.

1. Apply online

A short intake form, about five minutes. Have your medication list and CF diagnosis records nearby.

2. See a physician

An appointment of about fifteen minutes with a physician licensed in your state. You agree the time with the physician; keep an hour free.

3. Get the recommendation

If approved, it can be signed and in your account soon after the appointment, sometimes within about 15 minutes, depending on your state.

4. Register with your state

Where a state runs a registry, you file there next. The processing time is the state’s, not ours.

4.6out of 5 on Google

Across 250 reviews from patients in the states where we are licensed. We do not sort them by score and do not hide the low ones.

  • 150,000+patients evaluated – everyone who has been through an appointment with us, in every state where we are licensed
  • Since 2017doing only this: online evaluations for medical cannabis programs, and nothing else on the side

Prices differ by state and are shown on how the medical card works before checkout; a state registration fee, where one exists, goes to the state. Your documents can be downloaded again at any time from your account, renewal and other common questions are answered on the medical card FAQ, and there are separate routes for veterans and low-income patients.

Medical card or buying without one: what a card changes for people with CF

With a card

Products from the state program are lab-tested and labeled with their THC and CBD content, so you can tell your CF team exactly what you take. Depending on the state, patients pay lower taxes, may hold more, can buy from age 18 where adult use starts at 21, and sometimes may grow.

Without one

Hemp-derived CBD and delta-8 products sold in shops and online sit outside the program’s testing, and labels can be wrong about strength. For someone whose modulator level depends on how much CBD they take, an unknown dose is the problem.

See the rules in your state first

Talk to a licensed physician about cystic fibrosis and medical cannabis

If you remember three things from this page, make them these.

  • Your lungs come first: smoke and vapor work against CF airways, whatever is in them.
  • Any form, CBD-only oil included, passes through the liver that clears your modulator, so your CF team needs to know.
  • The evidence for symptom relief in CF is thin, and a physician weighs it against your own medicines, not a page.

The next step is an evaluation with a physician licensed in your state, with no promise about the outcome. Bring your medication list and your questions for the CF team. The physicians who review our medical content are listed on our doctors page, and every study cited here is in the reference list at the end.

Cystic fibrosis and medical cannabis: frequently asked questions

Can you treat or cure cystic fibrosis?

Cystic fibrosis cannot be cured yet, but it is treatable. CFTR modulators such as Trikafta help the faulty protein work and can be used by up to 90% of people with CF [9], alongside airway clearance, enzymes, vitamins and, when needed, a lung transplant. Gene therapies are still in trials.

Is cystic fibrosis contagious?

No. CF is a gene change present from birth and cannot be caught. People with CF can pass lung bacteria to each other, which is why they keep at least 6 feet apart [4] and should not share pipes or vapes.

How is cystic fibrosis inherited if both parents are carriers?

Each pregnancy has a 25% chance of a child with CF, a 50% chance of a carrier and a 25% chance of neither [5]. You can try other combinations in the inheritance calculator above.

How long can you live with cystic fibrosis?

Children born with CF between 2019 and 2023 are expected to live 61 years on average, and half of babies born with CF in 2023 are expected to reach 68 or older [6]. Gene variants, modulator access and lung function shape each person’s outlook.

Can medical cannabis treat cystic fibrosis?

No. Cannabis does not improve lung function, infections or the CFTR defect. Some people with CF use it for pain, sleep or anxiety, but no trial has tested it for those symptoms in CF [2].

Can people with cystic fibrosis smoke or vape cannabis?

It is discouraged. Inhaling any smoke or vapor can worsen airway inflammation and speed lung decline in CF [1], and one case report describes collapsed lungs in a young man who smoked through a bong [13].

Does CBD interact with Trikafta?

It can. CBD blocks CYP3A4, the liver enzyme that clears elexacaftor, tezacaftor and ivacaftor, which may raise their levels and side effects [1][3]. Tell your CF team and pharmacist before starting any CBD product. More in the interactions section.

Do edibles or tinctures avoid the lung risks?

They avoid the airways. They do not avoid the liver, the interactions with modulators or the effects of THC, and edibles act late and last long, which makes extra doses easy to overdo. Which form, if any, is a decision to make with a physician.

Can cannabis use affect lung transplant eligibility?

It can come up. Concern about how cannabis use is recorded and how it affects transplant eligibility is named in the research [2], and each center sets its own policy. Ask your transplant center before using any form.

How many people with cystic fibrosis use cannabis?

In a Canadian clinic, 43% of 110 adults were current users [3]. In US studies, 15% of 373 charts recorded current use [2] and 29% of 226 people had used marijuana in the past year [11].

Does cystic fibrosis qualify for a medical marijuana card?

It depends on your state’s list. Some lists may name CF; others cover it through severe pain, wasting or nausea; some let a physician certify a debilitating condition. Check yours on medical marijuana laws by state.

I got a recommendation. Can I go to a dispensary right away?

In some states, yes. In most, you first register with the state program, which issues the card on its own timeline. Your recommendation and the next steps for your state are in your account.

More research on cannabis and cystic fibrosis

This page cites a selection of studies. Our research library holds every study we track on cannabis and cystic fibrosis, from laboratory work to clinical trials, and lets you filter them by cannabinoid, study type and year.

studies
45
in people
19
clinical trials
5

See the studies on cystic fibrosis

Share your experience

Leave an anonymous messageTell us what this page failed to answer, or where we got something wrong. It goes to the team, not onto the page, and no account or email is needed.
Share your storyA longer account of living with this condition, written for the people who arrive at this page next. Published with your first name, or anonymously if you ask.
Write a public commentAsk a question, correct us, or answer somebody else’s question at the foot of this page. Comments are public once they clear moderation.Add a comment

    💬

    How else can we help you?

    Tell us what you’d like to see, learn, or get from us next.

    🕶️
    100% anonymous — share what’s on your mind
    We will only use it if we need to follow up on your message.

      💬

      Share Your Story with the Dr. Weedy Community

      Your positive, negative, or neutral experience can really help others. Feel free to share it in a few clear, short sentences.

      🕶️
      Your contact details are encrypted and will never be shared publicly

      References

      15 sources
      1. 1. Ince HY, Phan H, Nasr SZ, et al. Clearing up the smoke: Physical and mental health considerations regarding cannabis use in adolescents with cystic fibrosis. Pediatr Pulmonol · 2023 · narrative_review DOI: 10.1002/ppul.26241 PMID: 36349504
      2. 2. Tillman EM, Gallaway KA, Colwell A, et al. Prevalence of cannabidiol use in persons with cystic fibrosis. Pediatr Pulmonol · 2024 · survey DOI: 10.1002/ppul.27244 PMID: 39239909
      3. 3. Dagenais R, Karlsen E, Lee K, et al. Evaluating the use and perceptions of cannabis and vaping post-cannabis legalization in people with cystic fibrosis and CFTR-related disorder: survey results from a large Canadian adult cystic fibrosis clinic. BMJ Open Respir Res · 2025 · survey DOI: 10.1136/bmjresp-2024-002715 PMID: 41448798
      4. 4. National Heart, Lung, and Blood Institute. Living With Cystic Fibrosis. 2026.
      5. 5. MedlinePlus Genetics, National Library of Medicine. Cystic fibrosis. 2026.
      6. 6. National Heart, Lung, and Blood Institute. What Is Cystic Fibrosis?. 2026.
      7. 7. National Heart, Lung, and Blood Institute. Cystic Fibrosis: Diagnosis. 2026.
      8. 8. National Library of Medicine. ICD-10-CM codes, Clinical Table Search Service. 2026.
      9. 9. National Heart, Lung, and Blood Institute. Cystic Fibrosis: Treatment. 2026.
      10. 10. Ghigo A, Prono G, Riccardi E, et al. Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches. Int J Mol Sci · 2021 · narrative_review DOI: 10.3390/ijms22041952 PMID: 33669352
      11. 11. Vaziri S, McGarry ME, Huang CY, et al. Time to be blunt: Substance use in cystic fibrosis. Pediatr Pulmonol · 2024 · cross_sectional DOI: 10.1002/ppul.26880 PMID: 38251844
      12. 12. Vaziri S, McGarry ME, Cuneo AA, et al. A Joint Conversation: People With Cystic Fibrosis’ Perception of Healthcare Teams’ Knowledge, Comfort, and Barriers in Discussing Substance Use. Pediatr Pulmonol · 2025 · survey DOI: 10.1002/ppul.71017 PMID: 40019020
      13. 13. Gao Z, Wood-Baker R, Harle R, et al. “Bong lung” in cystic fibrosis: a case report. J Med Case Rep · 2010 · case_report DOI: 10.1186/1752-1947-4-371 PMID: 21092085
      14. 14. Hamberger ES, Halpern-Felsher B Concern over tobacco and marijuana perceptions and use among adolescents and young adults with cystic fibrosis. Addict Behav · 2023 · survey DOI: 10.1016/j.addbeh.2023.107669 PMID: 36921439
      15. 15. Stephen MJ, Chowdhury J, Tejada LA, et al. Use of medical marijuana in cystic fibrosis patients. BMC Complement Med Ther · 2020 · survey DOI: 10.1186/s12906-020-03116-x PMID: 33109153
      0 Comments
      Security check required

      Our security system needs to verify your connection. Please reload the page and complete the quick verification — your details are safe and nothing was lost.